Opportunity Information: Apply for CDC RFA PS11 1116
Apply for CDC RFA PS11 1116
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Eliminating Mother to Child HIV Transmission in the United States through Continuous Quality Improvement The FIMR HIV Prevention Methodology" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.118 Acquired Immunodeficiency Syndrome (AIDS) Activity.
- This funding opportunity was created on Mar 29, 2011 and posted on Mar 29, 2011.
- Applicants must submit their applications by May 31, 2011. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $225,000.00 to eligible and selected applicants.
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Public and State controlled institutions of higher education County governments Others (see text field entitled Additional Information on Eligibility for clarification) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Native American tribal governments (Federally recognized) State governments For profit organizations other than small businesses Private institutions of higher education Special district governments Native American tribal organizations (other than Federally recognized tribal governments) Small businesses Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education City or township governments.
- Eligible applicants that can apply for this funding opportunity are Nonprofit with 501C3 IRS status (other than institution of higher education) Nonprofit without 501C3 IRS status (other than institution of higher education) For profit organizations (other than small business) Small, minority, and women owned businesses Universities Colleges Research institutions Hospitals Community based organizations Faith based organizations Federally recognized or state recognized American Indian/Alaska Native tribal governments American Indian/Alaska native tribally designated organizations Alaska Native health corporations Urban Indian health organizations Tribal epidemiology centers State and local governments or their Bona Fide Agents (this includes the District of Columbia, the Commonwealth of Puerto Rico, the Virgin Islands, the Commonwealth of the Northern Marianna Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau) Political subdivisions of States (in consultation with States) Non domestic (non U.S.) entity A Bona Fide Agent is an agency/organization identified by the state as eligible to submit an application under the state eligibility in lieu of a state application. If applying as a bona fide agent of a state or local government, a legal, binding agreement from the state or local government as documentation of the status is required. Attach with Other Attachment Forms when submitting via www.grants.gov.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
This CDC funding opportunity (Funding Opportunity Number CDC RFA PS11-1116) focused on eliminating mother-to-child HIV transmission in the United States by expanding the use of a structured, continuous quality improvement approach known as the FIMR HIV Prevention Methodology (FHPM). FHPM builds on the Fetal and Infant Mortality Review (FIMR) model, which is typically used to understand and prevent poor birth outcomes by reviewing cases, identifying system gaps, and implementing practical changes across healthcare and community settings. In this specific HIV prevention context, the methodology is aimed at strengthening local prevention, screening, treatment, and care systems so that pregnant people with HIV are identified early, linked to appropriate medical care, supported through pregnancy and delivery, and maintained in care to reduce the risk of perinatal transmission to as close to zero as possible.
The central purpose of the program was twofold: first, to broadly disseminate FHPM so it could be adopted consistently across the country; and second, to provide hands-on technical assistance and operational support to about 60 communities implementing FHPM. Rather than funding dozens of separate local projects directly, the CDC anticipated making a single award under a cooperative agreement to establish or operate a FIMR HIV Prevention Methodology National Resource Center. That Resource Center concept implies a hub-and-spoke model where one nationally supported entity helps multiple communities launch and sustain the FHPM process, including guidance on organizing local review teams, standardizing procedures, using data appropriately, translating findings into quality improvement actions, and troubleshooting implementation challenges.
The opportunity was positioned as supporting several Healthy People 2020 priority areas, including HIV, maternal/infant/child health, public health infrastructure, access to quality health services, and family planning. In practice, that alignment reflects the reality that preventing perinatal HIV transmission depends on more than clinical care alone. It requires coordinated systems that ensure timely HIV testing before and during pregnancy, rapid initiation and adherence to antiretroviral therapy, effective prenatal and delivery planning, appropriate infant prophylaxis and follow-up testing, partner services when appropriate, and removal of barriers such as lack of insurance coverage, transportation issues, stigma, fragmented care, and missed opportunities for engagement.
Administratively, this was a discretionary funding opportunity using a cooperative agreement mechanism, which generally means the CDC expected to have substantial involvement in the project’s direction, performance monitoring, and alignment with national priorities. The funding activity category was Health, and the CFDA number listed was 93.118 (Acquired Immunodeficiency Syndrome (AIDS) Activity). The CDC expected to make one award, with an estimated total funding amount of $225,000. The posting and creation date were March 29, 2011, and the application closing date was May 31, 2011, with the opportunity later archived on June 30, 2011. No cost sharing or matching requirement was indicated.
Eligibility was intentionally broad and included many types of organizations that could credibly serve as a national technical assistance center. Eligible applicants ranged from nonprofit organizations (with or without 501(c)(3) status), universities and colleges, research institutions, hospitals, community-based and faith-based organizations, and state, local, tribal, and territorial governments, to for-profit organizations (including small businesses, and small/minority/women-owned businesses). The eligibility language also included tribal entities (federally or state recognized governments, tribally designated organizations, Alaska Native health corporations, urban Indian health organizations, and tribal epidemiology centers) and U.S. territories and freely associated states noted in the announcement. The opportunity also allowed non-U.S. entities to apply, and it clarified that a state or local government could designate a bona fide agent to apply on its behalf, provided a legal, binding agreement documenting that status was submitted with the application.
From an operational standpoint, the funded National Resource Center would be expected to help communities apply FHPM in a consistent and measurable way, emphasizing continuous quality improvement rather than one-time planning. That typically means supporting communities in forming multidisciplinary teams, conducting systematic reviews to identify missed prevention opportunities, mapping the service system and handoffs across providers, prioritizing feasible improvements, implementing changes, and tracking whether those changes actually improve outcomes like early identification of HIV in pregnancy, sustained viral suppression during pregnancy, appropriate delivery management, and completion of infant testing and follow-up. The overall intent was to strengthen local prevention and care systems so that preventable transmissions are identified as system failures that can be corrected, not as isolated individual events.
For applicants or interested parties at the time, the CDC directed users to the full announcement (referenced as available via the "Full Announcement" link in the posting). Technical issues accessing the full announcement were handled through the CDC Procurement and Grants Office Technical Information Management Section (TIMS), with the phone number listed as 770-488-2700.
Frequently Asked Questions (FAQs)
1) What is this funding opportunity?
This is a CDC discretionary funding opportunity under Funding Opportunity Number (FON) CDC RFA PS11-1116. It was designed to support efforts to eliminate mother-to-child (perinatal) HIV transmission in the United States by expanding use of the FIMR HIV Prevention Methodology (FHPM) through a national technical assistance and support hub.
2) What is the main goal of the program?
The program goal was to reduce the risk of perinatal HIV transmission to as close to zero as possible by strengthening local prevention, screening, treatment, and care systems so that pregnant people with HIV are identified early, linked to appropriate medical care, supported through pregnancy and delivery, and maintained in care.
3) What is FHPM (FIMR HIV Prevention Methodology)?
FHPM is a structured, continuous quality improvement approach adapted for HIV prevention. It builds on the Fetal and Infant Mortality Review (FIMR) model, which is commonly used to understand and prevent poor birth outcomes by reviewing cases, identifying system gaps, and implementing practical changes across healthcare and community settings.
4) How does FHPM relate to the traditional FIMR model?
FHPM builds on the FIMR approach of systematic review and action. In this HIV prevention context, the methodology focuses on identifying missed opportunities and system failures related to HIV prevention and care during pregnancy and the perinatal period, then translating findings into measurable improvements.
5) What kinds of issues does FHPM aim to improve in communities?
FHPM is intended to strengthen local systems supporting prevention and care, including timely HIV testing before and during pregnancy, rapid linkage to care, treatment adherence support, prenatal and delivery planning, infant prophylaxis and follow-up testing, partner services when appropriate, and addressing barriers like lack of insurance, transportation challenges, stigma, fragmented care, and missed engagement opportunities.
6) What were the two central purposes of this CDC program?
The program purpose was twofold: (1) to broadly disseminate FHPM so it could be adopted consistently across the country, and (2) to provide hands-on technical assistance and operational support to approximately 60 communities implementing FHPM.
7) Did CDC plan to fund many local projects directly?
No. Instead of directly funding dozens of separate local projects, CDC anticipated making a single cooperative agreement award to establish or operate a FHPM National Resource Center that would support many communities.
8) What is the National Resource Center model described in the opportunity?
The opportunity envisioned a hub-and-spoke approach where one nationally supported entity (the Resource Center) helps multiple communities launch and sustain FHPM. This includes guidance on organizing local review teams, standardizing procedures, using data appropriately, translating findings into quality improvement actions, and troubleshooting implementation challenges.
9) Approximately how many awards did CDC expect to make?
CDC expected to make one award.
10) What was the estimated total funding amount?
The estimated total funding amount was $225,000.
11) What funding mechanism was used?
The opportunity used a cooperative agreement mechanism.
12) What does a cooperative agreement imply for how the project would be run?
A cooperative agreement generally means CDC expected substantial involvement in the project, including direction, performance monitoring, and ensuring alignment with national priorities.
13) What was the funding activity category?
The funding activity category was Health.
14) What CFDA number was associated with this opportunity?
The CFDA number listed was 93.118 (Acquired Immunodeficiency Syndrome (AIDS) Activity).
15) Was cost sharing or matching required?
No cost sharing or matching requirement was indicated.
16) When was the opportunity posted and when did it close?
The posting and creation date were March 29, 2011. The application closing date was May 31, 2011.
17) Is this opportunity still active?
No. The opportunity was later archived on June 30, 2011.
18) Who was eligible to apply?
Eligibility was broad and included nonprofit organizations (with or without 501(c)(3) status), universities and colleges, research institutions, hospitals, community-based and faith-based organizations, and state, local, tribal, and territorial governments.
19) Were for-profit organizations eligible?
Yes. For-profit organizations were eligible, including small businesses and small/minority/women-owned businesses.
20) Which tribal entities were included as eligible applicants?
The eligibility language included federally or state recognized tribal governments, tribally designated organizations, Alaska Native health corporations, urban Indian health organizations, tribal epidemiology centers, and other tribal entities described in the announcement.
21) Were U.S. territories and freely associated states included?
Yes. The announcement noted U.S. territories and freely associated states.
22) Could non-U.S. entities apply?
Yes. The opportunity allowed non-U.S. entities to apply.
23) Could a state or local government apply through an agent?
Yes. A state or local government could designate a bona fide agent to apply on its behalf.
24) What documentation was required if applying as a bona fide agent?
The application needed to include a legal, binding agreement documenting the bona fide agent status.
25) What kind of work would the funded National Resource Center be expected to support in communities?
The Resource Center would be expected to help communities apply FHPM consistently and measurably as an ongoing continuous quality improvement effort. This includes supporting communities to form multidisciplinary teams, conduct systematic reviews to identify missed prevention opportunities, map service systems and provider handoffs, prioritize feasible improvements, implement changes, and track whether changes improve outcomes.
26) What types of outcomes or improvements were implied by the program description?
The description emphasized improvements such as earlier identification of HIV in pregnancy, sustained viral suppression during pregnancy, appropriate delivery management, and completion of infant testing and follow-up.
27) How does the program frame preventable perinatal HIV transmissions?
The intent was to strengthen systems so that preventable transmissions are identified as system failures that can be corrected, rather than treated as isolated individual events.
28) How did this opportunity align with Healthy People 2020?
It was positioned as supporting Healthy People 2020 priority areas including HIV, maternal/infant/child health, public health infrastructure, access to quality health services, and family planning.
29) Where were applicants directed to find full details?
Applicants were directed to the full announcement via the "Full Announcement" link in the posting.
30) Who could be contacted for technical issues accessing the full announcement?
Technical issues were handled through the CDC Procurement and Grants Office Technical Information Management Section (TIMS) at 770-488-2700.
Browse more opportunities from the same agency: Centers for Disease Control and Prevention
Browse more opportunities from the same category: Health
Next opportunity: Clear Creek Environmental Water Program Implementation Development
Previous opportunity: 2011 National Survey of Indigent Defense
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA PS11 1116
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA PS11 1116) also looked into and applied for these:
| Funding Opportunity |
|---|
| PPHF 2012 Immunization Capacity Building Assistance to Strengthen Public Health Immunization Infrastructure and Performance financed in part by 2012 Prevention and Public Health Funds Apply for CDC RFA IP11 1107PPHF11 Funding Number: CDC RFA IP11 1107PPHF11 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Next Generation PrEP II (R01) Apply for RFA AI 11 023 Funding Number: RFA AI 11 023 Agency: National Institutes of Health Category: Health Funding Amount: $300,000 |
| Cooperative Agreements for Screening, Brief Intervention and Referral to Treatment Apply for TI 11 005 Funding Number: TI 11 005 Agency: Substance Abuse Mental Health Services Adminis. Category: Health Funding Amount: $1,666,000 |
| Limited Competition for the Continuation of Rare Diseases Clinical Research Consortia in the Rare Diseases Clinical Research Network (U54) Apply for PAR 11 187 Funding Number: PAR 11 187 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Optimizing Fidelity of Empirically Supported Behavioral Treatments for Mental Disorders (R21/R33) Apply for RFA MH 12 050 Funding Number: RFA MH 12 050 Agency: National Institutes of Health Category: Health Funding Amount: $225,000 |
| Strengthening Angolan Systems for Health (SASH) Apply for RFA674 11 32 Funding Number: RFA674 11 32 Agency: South Africa USAID Pretoria Category: Health Funding Amount: $33,000,000 |
| Support of NIAMS Program Project Grants (P01) Apply for PAR 11 188 Funding Number: PAR 11 188 Agency: National Institutes of Health Category: Health Funding Amount: $1,000,000 |
| Dental Reimbursement Program Apply for HRSA 11 097 Funding Number: HRSA 11 097 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Public Health Prevention Fund Streamlined Surveillance for Ventilator Associated Pneumonia Reducing Burden and Demonstrating Preventability Apply for CDC RFA CK11 0010101PPHF11 Funding Number: CDC RFA CK11 0010101PPHF11 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,508,825 |
| Public Prevention Health Fund Pacific Islands Supplemental Funding for Five Year US Affiliated Pacific Island Collaborative Performance Agreement for Tobacco Control, Diabetes Prevention and Control, and the Behavioral Risk Factor Surveillance System Apply for CDC RFA DP09 9020302PPHF11 Funding Number: CDC RFA DP09 9020302PPHF11 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $50,000 |
| Integrating Multi Dimensional Data to Explore Mechanisms Underlying Mental Disorders (RO1) Apply for RFA MH 12 020 Funding Number: RFA MH 12 020 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Program for Extramural/Intramural Alcohol Research Collaborations (U01) Apply for PAR 11 189 Funding Number: PAR 11 189 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
| Public Prevention Health Fund State Supplemental Funding for Healthy Communities, Tobacco Prevention and Control, Diabetes Prevention and Control, and Behavioral Risk Factor Surveillance System Apply for CDC RFA DP09 9010201PPHF11 Funding Number: CDC RFA DP09 9010201PPHF11 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| State Implementation Grants for Improving Services for Children and Youth with ASD Apply for HRSA 11 071 Funding Number: HRSA 11 071 Agency: Health Resources and Services Administration Category: Health Funding Amount: $300,000 |
| State Implementation Planning Grants for Improving Services for Children and Youth with ASD Apply for HRSA 11 081 Funding Number: HRSA 11 081 Agency: Health Resources and Services Administration Category: Health Funding Amount: $75,000 |
| Control of NTD ENVISION Apply for RFA OAA 11 000007 Funding Number: RFA OAA 11 000007 Agency: Agency for International Development Category: Health Funding Amount: $250,000,000 |
| Specialized Alcohol Research Centers (P50) Apply for RFA AA 12 002 Funding Number: RFA AA 12 002 Agency: National Institutes of Health Category: Health Funding Amount: $1,800,000 |
| Comprehensive Alcohol Research Centers (P60) Apply for RFA AA 12 003 Funding Number: RFA AA 12 003 Agency: National Institutes of Health Category: Health Funding Amount: $2,000,000 |
| Emergency Countermeasure Dispensing Staffing Plan Apply for CDC RFA TP11 1102 Funding Number: CDC RFA TP11 1102 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $300,000 |
| Accelerating the Reduction of Malaria Morbidity and Mortality Program (ARM3) Apply for RFA 680 11 000001 Funding Number: RFA 680 11 000001 Agency: Benin USAID Cotonou Category: Health Funding Amount: $30,000,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA PS11 1116", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.